Core Viewpoint - CapsoVision, Inc. is set to release its third quarter 2025 financial results on November 13, 2025, and will host a conference call to discuss these results and provide a corporate update [1]. Group 1: Financial Results Announcement - The company will announce its third quarter 2025 financial results after the market closes on November 13, 2025 [1]. - A conference call and live webcast will take place on the same day at 1:30 pm PT / 4:30 pm ET to discuss the results [1]. Group 2: Company Overview - CapsoVision is a commercial-stage medical technology company focused on advanced imaging and AI-enabled solutions for gastrointestinal disease detection and diagnosis [3]. - The flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that provides high-resolution visualization of the small bowel [3]. - The upcoming product, CapsoCam Colon, features enhanced AI for non-invasive colon imaging and polyp detection [3]. - The company aims to expand its proprietary platform across multiple gastrointestinal indications, including esophageal and pancreatic disorders [3].

Core Viewpoint - CapsoVision, Inc. is actively participating in the 4th Annual ROTH Healthcare Opportunities Conference, highlighting its focus on advanced imaging and AI-enabled capsule endoscopy solutions [1] Company Overview - CapsoVision is a commercial-stage medical technology company dedicated to transforming the detection and diagnosis of gastrointestinal diseases through advanced imaging and AI solutions [3] - The flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that provides high-resolution visualization of the small bowel and supports cloud-based or direct video retrieval [3] - The upcoming product, CapsoCam Colon, features enhanced AI capabilities aimed at non-invasive colon imaging and polyp detection [3] - The company is developing a proprietary platform intended to expand across various gastrointestinal indications, including esophageal and pancreatic disorders [3]